Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synovium

Osteoarthritis and Cartilage

Volumn 20, Issue 4, 2012, Pages 314-322

  Chung, J I ^a   Barua, S ^a   Choi, B H ^b   Min, B H ^a,c   Han, H C ^d   Baik, E J ^a  

^a Ajou University School of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Ajou University Medical Center   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Anti inflammation; Arthritis; Low intensity ultrasound; Synovial hyperplasia

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FREUND ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1 PROTEIN; MYELOPEROXIDASE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL INFILTRATION; DISEASE SEVERITY; EDEMA; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KNEE; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNOVITIS; SYNOVIUM; ULTRASOUND;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CHEMOTAXIS, LEUKOCYTE; EDEMA; INFLAMMATION MEDIATORS; JOINTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR5; SYNOVIAL MEMBRANE; SYNOVITIS; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 84858620294     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.01.005     Document Type: Article

References (49)

1. Neugebauer V., Han J.S., Adwanikar H., Fu Y., Ji G. Techniques for assessing knee joint pain in arthritis. Mol Pain 2007, 3:8.
2. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-150.
3. Peana A.T., Bennardini F., Buttu L., Pippia P., Meloni M.A., Stuffler R.G., et al. Effect of simulated microgravity on PGE2-induced edema and hyperalgesia in rat paws: pharmacological data and biochemical correlates. J Gravit Physiol 2004, 11:P41-P42.
4. Lascelles B.D., King S., Roe S., Marcellin-Little D.J., Jones S. Expression and activity of COX-1 and 2 and 5-LOX in joint tissues from dogs with naturally occurring coxofemoral joint osteoarthritis. J Orthop Res 2009, 27:1204-1208.
5. Seki H., Fukuda M., Iino M., Takahashi T., Yoshioka N. Immunohistochemical localization of cyclooxygenase-1 and -2 in synovial tissues from patients with internal derangement or osteoarthritis of the temporomandibular joint. Int J Oral Maxillofac Surg 2004, 33:687-692.
6. Sano H., Hla T., Maier J.A., Crofford L.J., Case J.P., Maciag T., et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992, 89:97-108.
7. Mitchell J.A., Evans T.W. Cyclooxygenase-2 as a therapeutic target. Inflamm Res 1998, 47(Suppl 2):S88-S92.
8. Scott D.L., Wolfe F., Huizinga T.W. Rheumatoid arthritis. Lancet 2010, 376:1094-1108.
9. Seed S.M., Dunican K.C., Lynch A.M. Osteoarthritis: a review of treatment options. Geriatrics 2009, 64:20-29.
10. Pearson C.M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956, 91:95-101.
11. Butler S.H., Godefroy F., Besson J.M., Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain 1992, 48:73-81.
12. Gauldie S.D., McQueen D.S., Clarke C.J., Chessell I.P. A robust model of adjuvant-induced chronic unilateral arthritis in two mouse strains. J Neurosci Methods 2004, 139:281-291.
13. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7:33-42.
14. Schett G., Smolen J.S. New insights in the mechanism of bone loss in arthritis. Curr Pharm Des 2005, 11:3039-3049.
15. Attur M., Samuels J., Krasnokutsky S., Abramson S.B. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?. Best Pract Res Clin Rheumatol 2010, 24:71-79.
16. Chan Y.S., Hsu K.Y., Kuo C.H., Lee S.D., Chen S.C., Chen W.J., et al. Using low-intensity pulsed ultrasound to improve muscle healing after laceration injury: an in vitro and in vivo study. Ultrasound Med Biol 2010, 36:743-751.
17. Khanna A., Nelmes R.T., Gougoulias N., Maffulli N., Gray J. The effects of LIPUS on soft-tissue healing: a review of literature. Br Med Bull (Oxford) 2009, 89:169-182.
18. Pilla A.A., Mont M.A., Nasser P.R., Khan S.A., Figueiredo M., Kaufman J.J., et al. Non-invasive low-intensity pulsed ultrasound accelerates bone healing in the rabbit. J Orthop Trauma 1990, 4:246-253.
19. Rutjes A.W., Nüesch E., Sterchi R., Jüni P. Therapeutic ultrasound for osteoarthritis of the knee or hip. Cochrane Database Sys Rev (CDSR) 2010, CD003132.
20. Park S.R., Jang K.W., Park S.H., Cho H.S., Jin C.Z., Choi M.J., et al. The effect of sonication on simulated osteoarthritis. Part I: effects of 1 MHz ultrasound on uptake of hyaluronan into the rabbit synovium. Ultrasound Med Biol 2005, 31:1551-1558.
21. Gurkan I., Ranganathan A., Yang X., Horton W.E., Todman M., Huckle J., et al. Modification of osteoarthritis in the guinea pig with pulsed low-intensity ultrasound treatment. Osteoarthritis Cartilage 2010, 18:724-733.
22. Naito K., Watari T., Muta T., Furuhata A., Iwase H., Igarashi M., et al. Low-intensity pulsed ultrasound (LIPUS) increases the articular cartilage type II collagen in a rat osteoarthritis model. J Orthop Res 2010, 28:361-369.
23. Hsieh Y.L. Effects of ultrasound and diclofenac phonophoresis on inflammatory pain relief: suppression of inducible nitric oxide synthase in arthritic rats. Phys Ther 2006, 86:39-49.
24. Barton N.J., Strickland I.T., Bond S.M., Brash H.M., Bate S.T., Wilson A.W., et al. Pressure application measurement (PAM): a novel behavioural technique for measuring hypersensitivity in a rat model of joint pain. J Neurosci Methods 2007, 163:67-75.
25. Lu D.Y., Tang C.H., Liou H.C., Teng C.M., Jeng K.C., Kuo S.C., et al. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia. Br J Pharmacol 2007, 151:396-405.
26. Paliwal S., Mitragotri S. Therapeutic opportunities in biological responses of ultrasound. Ultrasonics 2008, 48:271-278.
27. Loyola-Sánchez A., Richardson J., MacIntyre N.J. Efficacy of ultrasound therapy for the management of knee osteoarthritis: a systematic review with meta-analysis. Osteoarthritis Cartilage 2010, 18:1117-1126.
28. Parvizi J., Wu C.C., Lewallen D.G., Greenleaf J.F., Bolander M.E. Low-intensity ultrasound stimulates proteoglycan synthesis in rat chondrocytes by increasing aggrecan gene expression. J Orthop Res 1999, 17:488-494.
29. Nishikori T., Ochi M., Uchio Y., Maniwa S., Kataoka H., Kawasaki K., et al. Effects of low-intensity pulsed ultrasound on proliferation and chondroitin sulfate synthesis of cultured chondrocytes embedded in Atelocollagen gel. J Biomed Mater Res 2002, 59:201-206.
30. Choi B.H., Woo J.I., Min B.H., Park S.R. Low-intensity ultrasound stimulates the viability and matrix gene expression of human articular chondrocytes in alginate bead culture. J Biomed Mater Res Part A 2006, 79:858-864.
31. Duque J., Diaz-Munoz M.D., Fresno M., Iniguez M.A. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell Signal 2006, 18:1262-1269.
32. Sakaki H., Matsumiya T., Kusumi A., Imaizumi T., Satoh H., Yoshida H., et al. Interleukin-1beta induces matrix metalloproteinase-1 expression in cultured human gingival fibroblasts: role of cyclooxygenase-2 and prostaglandin E2. Oral Dis 2004, 10:87-93.
33. Kuiper S., Joosten L.A., Bendele A.M., Edwards C.K., Arntz O.J., Helsen M.M., et al. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 1998, 10:690-702.
34. van den Berg W.B., Joosten L.A., Kollias G., van De Loo F.A. Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann Rheum Dis 1999, 58(Suppl 1):I40-I48.
35. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996, 14:397-440.
36. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996, 97:2672-2679.
37. Siegle I., Klein T., Backman J.T., Saal J.G., Nusing R.M., Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998, 41:122-129.
38. Cha H.S., Ahn K.S., Jeon C.H., Kim J., Koh E.M. Inhibitory effect of cyclo-oxygenase-2 inhibitor on the production of matrix metalloproteinases in rheumatoid fibroblast-like synoviocytes. Rheumatol Int 2004, 24:207-211.
39. Clancy R.M., Amin A.R., Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998, 41:1141-1151.
40. Rao P., Knaus E.E. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 2008, 11:81s-110s.
41. Harris E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990, 322:1277-1289.
42. Desmetz C., Lin Y.L., Mettling C., Portales P., Noel D., Clot J., et al. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes. Clin Immunol 2007, 123:148-154.
43. Arend W.P. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum 2001, 45:101-106.
44. Wright H.L., Moots R.J., Bucknall R.C., Edwards S.W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010, 49:1618-1631.
45. Lefkowitz D.L., Lefkowitz S.S. Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited. Immunol Cell Biol 2001, 79:502-506.
46. Steinbeck M.J., Nesti L.J., Sharkey P.F., Parvizi J. Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Orthop Res 2007, 25:1128-1135.
47. Fernandes R.M., Silva N.P., Sato E.I. Increased myeloperoxidase plasma levels in rheumatoid arthritis. Rheumatol Int 2011.
48. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996, 224:855-862.
49. Ohsawa K., Imai Y., Kanazawa H., Sasaki Y., Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 2000, 113(Pt 17):3073-3084.